ACC releases CardioSmart 'Survival Guides' for five common heart problems

In recognition of American Heart Month, the American College of Cardiology (ACC) today released CardioSmart "Survival Guides" for five of the most common heart problems: coronary artery disease, heart failure, arrhythmia, hypertension and heart attack. The Survival Guides are part of the ACC's CardioSmart National Care Initiative, a patient-centered campaign to engage people to play an active role in their own heart health and empower them to make better, healthier lifestyle choices.

Developed by cardiologists for their patients, the Survival Guides are designed to help patients better understand and manage their condition and facilitate productive discussion with their physicians. The Guides provide patients with clear, concise definitions of each condition; tips for living well with each condition; and important questions to ask their health care team.

"Navigating the vast amount of information available on various heart conditions can be overwhelming, confusing, and frustrating," said Ralph G. Brindis, M.D., M.P.H., president of the American College of Cardiology. "These Survival Guides are designed to take some of the guesswork out of taking care of your heart and encourage open discussion with your cardiologist. Something as simple as educating yourself and making small changes every day can have a profound effect on your heart health."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis